September 5, 2019
A drug developed by researchers at the Renaissance School of Medicine at Stony Brook University that targets enzymes involved in the development of pancreatic cancer cells is showing promise for improved treatment of metastatic pancreatic cancer.
Kevin Reed’s research interests include understanding the capability of global climate models to simulate extreme weather events and the impact of model design choices on the simulation of such extremes in a global context. One specific area of his research has focused on the ability of the National Center for Atmospheric Research’s Community Atmosphere Model (CAM) to simulate tropical cyclones at high-resolutions. Additionally, he studies how extreme events, including tropical cyclones, may change as a result of a changing climate.
Keeping you informed about Stony Brook University with a compilation of news and highlights from around the Web.